← Back to Home

How Does Andes Hantavirus Grip Cells? Cryo-EM Reveals a Binding Pocket Deep Within the Spike

An AI-designed scaffold helped researchers resolve how the virus engages a human receptor: the entry point lies within a narrow groove that is difficult for conventional antibodies to reach, offering new clues for designing molecules to block viral attachment.

By SURL BioNews

To stop a virus from invading, researchers first need a clear view of how it grips cells. Andes hantavirus hides this crucial contact site deep within its surface spike: a human receptor can reach inside, but conventional antibodies struggle to follow the same path. A new study maps this concealed entry point, providing a more concrete basis for designing antiviral molecules.

The study was published in *Nature* on October 21 through a collaboration involving Albert Einstein College of Medicine, the Institut Pasteur, Louisiana State University Health Sciences Center Shreveport, and other institutions. Researchers already knew that Andes virus uses protocadherin-1 (PCDH1) on the cell surface to enter its host; this study combined cryo-electron microscopy with functional experiments to reveal how the two engage.

The challenge was that isolated spike components could not reproduce the complete receptor-binding site. The team used an AI-designed protein scaffold to help assemble soluble viral spikes, then prepared them together with the receptor, stabilizing the complex sufficiently for structural analysis. AI served to build an experimental tool here; the way the virus and receptor engage was confirmed by near-atomic-resolution electron microscopy images and biochemical experiments.

The images show that four Gn glycoprotein components together enclose a deep pocket, into which the terminal region of a single PCDH1 molecule inserts asymmetrically. In other words, the virus must arrange its components into a complete structure to form this gripping site. Mutational analysis also identified three protein loop regions that shape the binding pocket, providing functional support for the contacts revealed by the images.

This structure also explains the spatial constraints antibodies face. The slender shape of PCDH1 is suited to reaching deep into the pocket, whereas the binding fragments of conventional antibodies are bulkier. However, structural and functional analyses of four neutralizing antibodies showed that antibodies can still hinder receptor access by covering the entrance or creating steric barriers around it; a deeply concealed pocket does not mean the virus can evade antibodies entirely.

Andes virus can cause severe hantavirus cardiopulmonary syndrome and has a known capacity for human-to-human transmission, making research into blocking infection particularly urgent. Albert Einstein College of Medicine's account of the research suggested attempting to design long, narrow molecules that could reach into the pocket and prevent receptor binding. Coverage of the same findings in *Chemical & Engineering News* also noted that the discovery could offer clues for antiviral research on other New World hantaviruses, including Sin Nombre virus.

Many hurdles remain between visualizing the entry point and developing a drug. These findings are based primarily on engineered proteins, structural analysis, and laboratory functional tests, and do not yet demonstrate that molecules designed to target the pocket can prevent or treat infection in humans. Future candidates must demonstrate that they can effectively block the virus, remain active in the body, and have acceptable safety; this structural map offers a direction that can be tested.

References

  1. Genetic Engineering and Biotechnology News
  2. Albert Einstein College of Medicine via PR Newswire
  3. Chemical & Engineering News